Hypotension,ControlledNCT03917004
Correlation Analysis of the Effects of Management Pressure Goals and Control Volume Goals in Patients in Spinal Surgery
A study testing Nitroglycerin in people with Hypotension,Controlled, run by Liang Bing at 1 site in China.
Trial summary
The investigators study 160 patients undergoing spinal surgery.Participants will be randomly divided into study group and control group.The study group will receive controlled hypotension by nitroglycerin and be divided into 3 groups according to CI. Read more about this study
- Who is it for?
- Ages 35 to 70 yearsHealthy volunteers can take part
- Conditions the study is for
- Hypotension,Controlled
- What is being tested?
- Nitroglycerin
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 160 participants
- Where
- 1 siteChina
- Study dates
- 1 Apr 2019to 30 Sep 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 35 to 70 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Aged between 35 and 70 years
- Patients, undergoing canal decompression, intervertebral disc extraction and pedicle screw fixation (1 vertebral body)
Who cannot join
- History of cardiovascular function
- congestive heart failure [CHF]
- coronary artery disease [CAD]
- cerebrovascular insuffiency)
- poorly controlled arterial hypertension
- pre-existing coagulation defects
- Patients taking anticoagulatory medication including aspirin
- Patients taking corticosteroid therapy
Trial locations and contacts
1 site in 1 country.
Yang contact
China1 site, 1 recruiting
- Recruiting
Guangzhou Red cross hospital
Guangzhou, Guangdong, 510220
Liang Bing, 020-34403854, 27291375@qq.com
About this study
Official title: Correlation Analysis of the Effects of Management Pressure Goals (Controlled Hypotension) and Control Volume Goals (Cardiac Output, Stroke Volume Variability, Central Venous Pressure) on Intraoperative Blood and Visual Field Quality
The investigators study 160 patients undergoing spinal surgery.Participants will be randomly divided into study group and control group.The study group will receive controlled hypotension by nitroglycerin and be divided into 3 groups according to CI.
Read the detailed description
This study will be done in Guangzhou Red Cross Hospital .The investigators study 160 patients aged from 45 to 70 years,weight from 48 to 68kg classified as American Society of Anesthesiologists (ASAs) physical status Ⅰ-Ⅱ who will be candidate for posterior decompression of vertebral canal,discectomy and internal fixation by pediclescrew(one centrum).The investigators excluded patients with cardiovascular and cerebrovascular diseases,hepatic or renal dysfunction,and patients receiving drugs that interfere with coagulation before surgery.
Patients randomly divided into study group(group H,n=120)and control group (group C,n=40).The study group according to CI(Cardiac Index) levels of intraoperative hypotension period(mean of CI at T2,T3,T4) were divided into three groups: 1st group: CI: 1.5-2.0 L /(min•m2), 2nd group: CI: 2.0-3.0 L /(min•m2), 3rd group: CI: 3.0-4.0 L /(min•m2),and which CI < 1.5 or CI > 4.0 was eliminated the experimental group, which, in control group, CI< 2.5 or CI >4.0 was eliminated the experimental group.
- Conditions
- Hypotension,Controlled
- Being tested
- Nitroglycerin
- Keywords
- controlled hypotension, cardiac output on, blood loss, surgical field, oxygen supply, oxygen consumption
- Medical subject headings
- Hypotension, Hemorrhage
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
NitroglycerinDrug
Also called Controlled Hypotension
The starting rate of "nitroglycerin" was 0.25 μg / kg / min and the mean arterial pressure (MAP) decreased to 80% of the baseline but not less than 70%.The drug infusion rate was adjusted so that the MAP was maintained in the range to the suture, and the administration was stopped and the blood pressure was gradually returned to the pre-depressurization level.
| Study group | Role | What they receive |
|---|---|---|
| hypotension group (group H ) | Experimental | particcipants in hypotension group are received controlled hypertension in the operation. Receives: Drug: Nitroglycerin |
| control group (group C ) | No intervention | participants in cotrol group are received no controlled hypertension in the operation |
What is being measured
The primary outcome is the main question the study is designed to answer.
cardiac index(CI) after the participants are taken into the operating room
CI(L/min/m^2)
Measured: during surgery
cardiac index(CI) after the induction
cardiac index (CI,L/min/m^2)
Measured: during surgery
cardiac index(CI) at 5 minutes after tubation
cardiac index (CI,L/min/m^2)
Measured: 5 minutes after tubation
cardiac index(CI) at 10 minutes after tubation
cardiac index (CI,L/min/m^2).
Measured: 10 minutes after tubation
cardiac index(CI) at 15 minutes after tubation
cardiac index (CI,L/min/m^2)
Measured: 15 minutes after tubation
cardiac index(CI) at 30 minutes after tubation
cardiac index (CI,L/min/m^2)
Measured: 30 minutes after tubation
cardiac index(CI) at 45 minutes after tubation
cardiac index (CI,L/min/m^2)
Measured: 45 minutes after tubation
cardiac index(CI) at the end of surgery
cardiac index (CI,L/min/m^2).
Measured: at the end of surgery
cardiac index(CI) at 1 minute after extubation
cardiac index (CI,L/min/m^2)
Measured: 1 minute after extubation
cardiac index(CI) at 5 minutes after extubation
cardiac index (CI,L/min/m^2)
Measured: 5 minutes after extubation
Secondary outcomes (120)
Partial pressure of oxygen after the participants are taken into the operating room
Partial pressure of oxygen (PaO2,mmHg)
Measured: during surgery
Arterial oxygen saturation after the participants are taken into the operating room
Arterial oxygen saturation (SaO2,%)
Measured: during surgery
Arterial blood hemoglobin after the participants are taken into the operating room
Arterial blood hemoglobin (Hb,g/L)
Measured: during surgery
Arterial blood lactate after the participants are taken into the operating room
Arterial blood lactate (Lac,mmol/L)
Measured: during surgery
Partial pressure central venous oxygen after the participants are taken into the operating room
Partial pressure central venous oxygen(PvO2,mmHg)
Measured: during surgery
Central venous blood oxygen saturation after the participants are taken into the operating room
Central venous blood oxygen saturation(ScvO2,%)
Measured: during surgery
Oxygen supply index after the participants are taken into the operating room
Oxygen supply index (DO2I,ml/min/m^2)
Measured: during surgery
Oxygen consumption index after the participants are taken into the operating room
Oxygen consumption index (VO2I,ml/min/m^2)
Measured: during surgery
Partial pressure of oxygen after the induction
Partial pressure of oxygen (PaO2,mmHg)
Measured: during surgery
Arterial oxygen saturation after the induction
Arterial oxygen saturation (SaO2,%)
Measured: during surgery
Arterial blood hemoglobin after the induction
Arterial blood hemoglobin (Hb,g/L)
Measured: during surgery
Arterial blood lactate after the induction
Arterial blood lactate (Lac,mmol/L)
Measured: during surgery
Partial pressure central venous oxygen after the induction
Partial pressure central venous oxygen(PvO2,mmHg)
Measured: during surgery
Central venous blood oxygen saturation after the induction
Central venous blood oxygen saturation(ScvO2,%)
Measured: during surgery
Oxygen supply index after the induction
Oxygen supply index (DO2I,ml/min/m^2)
Measured: during surgery
Oxygen consumption index after the induction
Oxygen consumption index (VO2I,ml/min/m^2)
Measured: during surgery
Partial pressure of oxygen at 5 minutes after tubation
Partial pressure of oxygen (PaO2,mmHg)
Measured: 5 minutes after tubation
Arterial oxygen saturation at 5 minutes after tubation
Arterial oxygen saturation (SaO2,%)
Measured: 5 minutes after tubation
Arterial blood hemoglobin at 5 minutes after tubation
Arterial blood hemoglobin (Hb,g/L)
Measured: 5 minutes after tubation
Arterial blood lactate at 5 minutes after tubation
Arterial blood lactate (Lac,mmol/L)
Measured: 5 minutes after tubation
Partial pressure central venous oxygen at 5 minutes after tubation
Partial pressure central venous oxygen(PvO2,mmHg)
Measured: 5 minutes after tubation
Central venous blood oxygen saturation at 5 minutes after tubation
Central venous blood oxygen saturation(ScvO2,%)
Measured: 5 minutes after tubation
Oxygen supply index at 5 minutes after tubation
Oxygen supply index (DO2I,ml/min/m^2)
Measured: 5 minutes after tubation
Oxygen consumption index at 5 minutes after tubation
Oxygen consumption index (VO2I,ml/min/m^2)
Measured: 5 minutes after tubation
Partial pressure of oxygen at 10 minutes after tubation
Partial pressure of oxygen (PaO2,mmHg)
Measured: 10 minutes after tubation
Arterial oxygen saturation at 10 minutes after tubation
Arterial oxygen saturation (SaO2,%)
Measured: 10 minutes after tubation
Arterial blood hemoglobin at 10 minutes after tubation
Arterial blood hemoglobin (Hb,g/L)
Measured: 10 minutes after tubation
Arterial blood lactate at 10 minutes after tubation
Arterial blood lactate (Lac,mmol/L)
Measured: 10 minutes after tubation
Partial pressure central venous oxygen at 10 minutes after tubation
Partial pressure central venous oxygen(PvO2,mmHg)
Measured: 10 minutes after tubation
Central venous blood oxygen saturation at 10 minutes after tubation
Central venous blood oxygen saturation(ScvO2,%)
Measured: 10 minutes after tubation
Oxygen supply index at 10 minutes after tubation
Oxygen supply index (DO2I,ml/min/m^2)
Measured: 10 minutes after tubation
Oxygen consumption index at 10 minutes after tubation
Oxygen consumption index (VO2I,ml/min/m^2)
Measured: 10 minutes after tubation
Partial pressure of oxygen at 15 minutes after tubation
Partial pressure of oxygen (PaO2,mmHg)
Measured: 15 minutes after tubation
Arterial oxygen saturation at 15 minutes after tubation
Arterial oxygen saturation (SaO2,%)
Measured: 15 minutes after tubation
Arterial blood hemoglobin at 15 minutes after tubation
Arterial blood hemoglobin (Hb,g/L)
Measured: 15 minutes after tubation
Arterial blood lactate at 15 minutes after tubation
Arterial blood lactate (Lac,mmol/L)
Measured: 15 minutes after tubation
Partial pressure central venous oxygen at 15 minutes after tubation
Partial pressure central venous oxygen(PvO2,mmHg)
Measured: 15 minutes after tubation
Central venous blood oxygen saturation at 15 minutes after tubation
Central venous blood oxygen saturation(ScvO2,%)
Measured: 15 minutes after tubation
Oxygen supply index at 15 minutes after tubation
Oxygen supply index (DO2I,ml/min/m^2)
Measured: 15 minutes after tubation
Calculated index at 15 minutes after tubation
Oxygen consumption index (VO2I,ml/min/m^2)
Measured: 15 minutes after tubation
Partial pressure of oxygen at 30 minutes after tubation
Partial pressure of oxygen (PaO2,mmHg)
Measured: 30 minutes after tubation
Arterial oxygen saturation at 30 minutes after tubation
Arterial oxygen saturation (SaO2,%)
Measured: 30 minutes after tubation
Arterial blood hemoglobin at 30 minutes after tubation
Arterial blood hemoglobin (Hb,g/L)
Measured: 30 minutes after tubation
Arterial blood lactate at 30 minutes after tubation
Arterial blood lactate (Lac,mmol/L)
Measured: 30 minutes after tubation
Partial pressure central venous oxygen at 30 minutes after tubation
Partial pressure central venous oxygen(PvO2,mmHg)
Measured: 30 minutes after tubation
Central venous blood oxygen saturation at 30 minutes after tubation
Central venous blood oxygen saturation(ScvO2,%)
Measured: 30 minutes after tubation
Oxygen supply index at 30 minutes after tubation
Oxygen supply index (DO2I,ml/min/m^2)
Measured: 30 minutes after tubation
Oxygen consumption index at 30 minutes after tubation
Oxygen consumption index (VO2I,ml/min/m^2)
Measured: 30 minutes after tubation
Partial pressure of oxygen at 45 minutes after tubation
Partial pressure of oxygen (PaO2,mmHg)
Measured: 45 minutes after tubation
Arterial oxygen saturation at 45 minutes after tubation
Arterial oxygen saturation (SaO2,%)
Measured: 45 minutes after tubation
Arterial blood hemoglobin at 45 minutes after tubation
Arterial blood hemoglobin (Hb,g/L)
Measured: 45 minutes after tubation
Partial pressure central venous oxygen at 45 minutes after tubation
Partial pressure central venous oxygen(PvO2,mmHg)
Measured: 45 minutes after tubation
Arterial blood lactate at 45 minutes after tubation
Arterial blood lactate (Lac,mmol/L)
Measured: 45 minutes after tubation
Oxygen supply index at 45 minutes after tubation
Oxygen supply index (DO2I,ml/min/m^2)
Measured: 45 minutes after tubation
Oxygen consumption index at 45 minutes after tubation
Oxygen consumption index (VO2I,ml/min/m^2)
Measured: 45 minutes after tubation
Central venous blood oxygen saturation at 45 minutes after tubation
Central venous blood oxygen saturation(ScvO2,%)
Measured: 45 minutes after tubation
Partial pressure of oxygen at the end of surgery
Partial pressure of oxygen (PaO2,mmHg)
Measured: at the end of surgery
Arterial oxygen saturation at the end of surgery
Arterial oxygen saturation (SaO2,%)
Measured: at the end of surgery
Arterial blood hemoglobin at the end of surgery
Arterial blood hemoglobin (Hb,g/L)
Measured: at the end of surgery
Arterial blood lactate at the end of surgery
Arterial blood lactate (Lac,mmol/L)
Measured: at the end of surgery
Partial pressure central venous oxygen at the end of surgery
Partial pressure central venous oxygen(PvO2,mmHg)
Measured: at the end of surgery
Central venous blood oxygen saturation at the end of surgery
Central venous blood oxygen saturation(ScvO2,%)
Measured: at the end of surgery
Oxygen supply index at the end of surgery
Oxygen supply index (DO2I,ml/min/m^2)
Measured: at the end of surgery
Oxygen consumption index at the end of surgery
Oxygen consumption index (VO2I,ml/min/m^2)
Measured: at the end of surgery
Partial pressure of oxygen at 1 minute after extubation
Partial pressure of oxygen (PaO2,mmHg)
Measured: 1 minute after extubation
Arterial oxygen saturation at 1 minute after extubation
Arterial oxygen saturation (SaO2,%)
Measured: 1 minute after extubation
Arterial blood hemoglobin at 1 minute after extubation
Arterial blood hemoglobin (Hb,g/L)
Measured: 1 minute after extubation
Arterial blood lactate at 1 minute after extubation
Arterial blood lactate (Lac,mmol/L)
Measured: 1 minute after extubation
Partial pressure central venous oxygen at 1 minute after extubation
Partial pressure central venous oxygen(PvO2,mmHg)
Measured: 1 minute after extubation
Central venous blood oxygen saturation at 1 minute after extubation
Central venous blood oxygen saturation(ScvO2,%)
Measured: 1 minute after extubation
Oxygen supply index at 1 minute after extubation
Oxygen supply index (DO2I,ml/min/m^2)
Measured: 1 minute after extubation
Oxygen consumption index at 1 minute after extubation
Oxygen consumption index (VO2I,ml/min/m^2)
Measured: 1 minute after extubation
Plartia pressure of oxygen at 5 minutes after extubation
Plartia pressure of oxygen (PaO2,mmHg)
Measured: 5 minutes after extubation
Arterial oxygen saturation at 5 minutes after extubation
Arterial oxygen saturation (SaO2,%)
Measured: 5 minutes after extubation
Arterial blood hemoglobin at 5 minutes after extubation
Arterial blood hemoglobin (Hb,g/L)
Measured: 5 minutes after extubation
Arterial blood lactate at 5 minutes after extubation
Arterial blood lactate (Lac,mmol/L)
Measured: 5 minutes after extubation
Partial pressure central venous oxygen at 5 minutes after extubation
Partial pressure central venous oxnyge(PvO2,mmHg)
Measured: 5 minutes after extubation
Central venous blood oxygen saturation at 5 minutes after extubation
Central venous blood oxygen saturation(ScvO2,%)
Measured: 5 minutes after extubation
Oxygen supply index at 5 minutes after extubation
Oxygen supply index (DO2I,ml/min/m^2)
Measured: 5 minutes after extubation
Oxygen consumption index at 5 minutes after extubation
Oxygen consumption index (VO2I,ml/min/m^2).
Measured: 5 minutes after extubation
mean artery pressure(MAP) after the participants are taken into the operatin after the participantsg room
MAP(mmHg)
Measured: during surgery
heart rate(HR) after the participants are taken into the operating room
HR(beat per minute)
Measured: during surgery
central venous pressure(CVP) after the participants are taken into the operating room
CVP(mmHg)
Measured: during surgery
variability of stroke volume(SVV) after the participants are taken into the operating room
SVV (%)
Measured: during surgery
mean artery pressure(MAP) after the induction
MAP(mmHg)
Measured: during surgery
heart rate(HR) after the induction
HR(heart rate,beat per minute)
Measured: during surgery
central venous pressure(CVP) after the induction
CVP(mmHg)
Measured: during surgery
variability of stroke volume(SVV) after the induction
SVV (variability of stroke volume,%)
Measured: during surgery
mean artery pressure(MAP) at 5 minutes after tubation
MAP(mmHg)m^2)
Measured: 5 minutes after tubation
heart rate(HR) at 5 minutes after tubation
HR(heart rate,beat per minute),
Measured: 5 minutes after tubation
central venous pressure(CVP) at 5 minutes after tubation
CVP(mmHg)
Measured: 5 minutes after tubation
variability of stroke volume(SVV) at 5 minutes after tubation
SVV (variability of stroke volume,%)
Measured: 5 minutes after tubation
mean artery pressure(MAP) at 10 minutes after tubation
MAP(mmHg)
Measured: 10 minutes after tubation
heart rate(HR) at 10 minutes after tubation
HR(heart rate,beat per minute)
Measured: 10 minutes after tubation
central venous pressure(CVP) at 10 minutes after tubation
CVP(mmHg)
Measured: 10 minutes after tubation
variability of stroke volume(SVV) at 10 minutes after tubation
SVV (variability of stroke volume,%)
Measured: 10 minutes after tubation
mean artery pressure(MAP) at 15 minutes after tubation
MAP(mmHg)
Measured: 15 minutes after tubation
heart rate(HR) at 15 minutes after tubation
HR(heart rate,beat per minute)
Measured: 15 minutes after tubation
central venous pressure(CVP) at 15 minutes after tubation
CVP(mmHg)
Measured: 15 minutes after tubation
variability of stroke volume(SVV) at 15 minutes after tubation
SVV (variability of stroke volume,%)
Measured: 15 minutes after tubation
mean artery pressure(MAP) at 30 minutes after tubation
MAP(mmHg)
Measured: 30 minutes after tubation
heart rate(HR) at 30 minutes after tubation
HR(heart rate,beat per minute)
Measured: 30 minutes after tubation
central venous pressure(CVP) at 30 minutes after tubation
CVP(mmHg)
Measured: 30 minutes after tubation
variability of stroke volume(SVV) at 30 minutes after tubation
SVV (variability of stroke volume,%)
Measured: 30 minutes after tubation
mean artery pressure(MAP) at 45 minutes after tubation
MAP(mmHg)
Measured: 45 minutes after tubation
heart rate(HR) at 45 minutes after tubation
HR(heart rate,beat per minute)
Measured: 45 minutes after tubation
central venous pressure(CVP) at 45 minutes after tubation
CVP(mmHg)
Measured: 45 minutes after tubation
variability of stroke volume(SVV) at 45 minutes after tubation
SVV (variability of stroke volume,%)
Measured: 45 minutes after tubation
mean artery pressure(MAP) at the end of surgery
MAP(mmHg)
Measured: at the end of surgery
central venous pressure(CVP) at the end of surgery
CVP(mmHg)
Measured: at the end of surgery
variability of stroke volume(SVV) at the end of surgery
SVV (variability of stroke volume,%)
Measured: at the end of surgery
heart rate(HR) at the end of surgery
HR(heart rate,beat per minute)
Measured: at the end of surgery
mean artery pressure(MAP) at 1 minute after extubation
MAP(mmHg)
Measured: 1 minute after extubation
heart rate(HR) at 1 minute after extubation
HR(heart rate,beat per minute)
Measured: 1 minute after extubation
variability of stroke volume(SVV) at 1 minute after extubation
SVV (variability of stroke volume,%)
Measured: 1 minute after extubation
central venous pressure(CVP) at 1 minute after extubation
CVP(mmHg)
Measured: 1 minute after extubation
mean artery pressure(MAP) at 5 minutes after extubation
MAP(mmHg)
Measured: 5 minutes after extubation
central venous pressure(CVP) at 5 minutes after extubation
CVP(mmHg)
Measured: 5 minutes after extubation
heart rate(HR) at 5 minutes after extubation
HR(heart rate,beat per minute)
Measured: 5 minutes after extubation
variability of stroke volume(SVV) at 5 minutes after extubation
SVV (variability of stroke volume,%)
Measured: 5 minutes after extubation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Apr 2019
- Study start1 Apr 2019
- Primary completion30 Sep 2019 (estimated)
- Study completion30 Sep 2019 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Hypotension,ControlledStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Investigator
- Enrolment
- 160 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Liang Bing
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Liang Bing, Guangzhou Red Cross Hospital
- Investigators
- Cao Yang, Study director, Guangzhou Red Cross Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03917004
- Sponsor's protocol ID
- 2018-032-01
- Status last verified
- Apr 2019
- First submitted
- 5 Mar 2019
- Last updated
- 16 Apr 2019
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Kako H, Gable A, Martin D, Beebe A, Thung A, Samora W, Klamar J, Bhalla T, Tobias JD. A prospective, open-label trial of clevidipine for controlled hypotension during posterior spinal fusion. J Pediatr Pharmacol Ther. 2015 Jan-Feb;20(1):54-60. doi: 10.5863/1551-6776-20.1.54.
PubMed 25859171Amr YM, Amin SM. Effects of preoperative beta-blocker on blood loss and blood transfusion during spinal surgeries with sodium nitroprusside-controlled hypotension. Saudi J Anaesth. 2012 Jul;6(3):263-7. doi: 10.4103/1658-354X.101219.
PubMed 23162401
Study at a glance
From the registry record, last updated by the sponsor on 16 Apr 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Correlation Analysis of the Effects of Management Pressure Goals (Controlled Hypotension) and Control Volume Goals (Cardiac Output, Stroke Volume Variability, Central Venous Pressure) on Intraoperative Blood and Visual Field Quality
- ClinicalTrials.gov ID
- NCT03917004
- Acronym / sponsor ID
- 2018-032-01
- Conditions
- Hypotension,Controlled
- Keywords
- controlled hypotension, cardiac output on, blood loss, surgical field, oxygen supply, oxygen consumption
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 160 participants (estimated)
- Lead sponsor
- Liang BingUniversity, hospital or other
- Study start
- 1 Apr 2019 (actual)
- Primary completion
- 30 Sep 2019 (estimated)
- Study completion
- 30 Sep 2019 (estimated)
- First posted
- 16 Apr 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The investigators study 160 patients undergoing spinal surgery.Participants will be randomly divided into study group and control group.The study group will receive controlled hypotension by nitroglycerin and be divided into 3 groups according to CI.
Detailed description
This study will be done in Guangzhou Red Cross Hospital .The investigators study 160 patients aged from 45 to 70 years,weight from 48 to 68kg classified as American Society of Anesthesiologists (ASAs) physical status Ⅰ-Ⅱ who will be candidate for posterior decompression of vertebral canal,discectomy and internal fixation by pediclescrew(one centrum).The investigators excluded patients with cardiovascular and cerebrovascular diseases,hepatic or renal dysfunction,and patients receiving drugs that interfere with coagulation before surgery.
Patients randomly divided into study group(group H,n=120)and control group (group C,n=40).The study group according to CI(Cardiac Index) levels of intraoperative hypotension period(mean of CI at T2,T3,T4) were divided into three groups: 1st group: CI: 1.5-2.0 L /(min•m2), 2nd group: CI: 2.0-3.0 L /(min•m2), 3rd group: CI: 3.0-4.0 L /(min•m2),and which CI < 1.5 or CI > 4.0 was eliminated the experimental group, which, in control group, CI< 2.5 or CI >4.0 was eliminated the experimental group.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| hypotension group (group H ) | Experimental | Drug: Nitroglycerinparticcipants in hypotension group are received controlled hypertension in the operation. |
| control group (group C ) | No intervention | –participants in cotrol group are received no controlled hypertension in the operation |
Who may qualify
- Ages
- 35 to 70 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Aged between 35 and 70 years
- Patients, undergoing canal decompression, intervertebral disc extraction and pedicle screw fixation (1 vertebral body)
Key exclusion criteria (8 listed)
- History of cardiovascular function
- poorly controlled arterial hypertension
- pre-existing coagulation defects
- Patients taking anticoagulatory medication including aspirin
- Patients taking corticosteroid therapy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| NitroglycerinAlso: Controlled HypotensionThe starting rate of "nitroglycerin" was 0.25 μg / kg / min and the mean arterial pressure (MAP) decreased to 80% of the baseline but not less than 70%.The drug infusion rate was adjusted so that the MAP was maintained in the range to the suture, and the administration was stopped and the blood pressure was gradually returned to the pre-depressurization level. | Drug | hypotension group (group H ) |
Primary outcome
cardiac index(CI) after the participants are taken into the operating room
Time frame: during surgery
CI(L/min/m^2)
cardiac index(CI) after the induction
Time frame: during surgery
cardiac index (CI,L/min/m^2)
cardiac index(CI) at 5 minutes after tubation
Time frame: 5 minutes after tubation
cardiac index (CI,L/min/m^2)
cardiac index(CI) at 10 minutes after tubation
Time frame: 10 minutes after tubation
cardiac index (CI,L/min/m^2).
cardiac index(CI) at 15 minutes after tubation
Time frame: 15 minutes after tubation
cardiac index (CI,L/min/m^2)
cardiac index(CI) at 30 minutes after tubation
Time frame: 30 minutes after tubation
cardiac index (CI,L/min/m^2)
cardiac index(CI) at 45 minutes after tubation
Time frame: 45 minutes after tubation
cardiac index (CI,L/min/m^2)
cardiac index(CI) at the end of surgery
Time frame: at the end of surgery
cardiac index (CI,L/min/m^2).
cardiac index(CI) at 1 minute after extubation
Time frame: 1 minute after extubation
cardiac index (CI,L/min/m^2)
cardiac index(CI) at 5 minutes after extubation
Time frame: 5 minutes after extubation
cardiac index (CI,L/min/m^2)
120 secondary outcomes
Partial pressure of oxygen after the participants are taken into the operating room
Time frame: during surgery
Arterial oxygen saturation after the participants are taken into the operating room
Time frame: during surgery
Arterial blood hemoglobin after the participants are taken into the operating room
Time frame: during surgery
Arterial blood lactate after the participants are taken into the operating room
Time frame: during surgery
Partial pressure central venous oxygen after the participants are taken into the operating room
Time frame: during surgery
Central venous blood oxygen saturation after the participants are taken into the operating room
Time frame: during surgery
Oxygen supply index after the participants are taken into the operating room
Time frame: during surgery
Oxygen consumption index after the participants are taken into the operating room
Time frame: during surgery
Partial pressure of oxygen after the induction
Time frame: during surgery
Arterial oxygen saturation after the induction
Time frame: during surgery
Arterial blood hemoglobin after the induction
Time frame: during surgery
Arterial blood lactate after the induction
Time frame: during surgery
Partial pressure central venous oxygen after the induction
Time frame: during surgery
Central venous blood oxygen saturation after the induction
Time frame: during surgery
Oxygen supply index after the induction
Time frame: during surgery
Oxygen consumption index after the induction
Time frame: during surgery
Partial pressure of oxygen at 5 minutes after tubation
Time frame: 5 minutes after tubation
Arterial oxygen saturation at 5 minutes after tubation
Time frame: 5 minutes after tubation
Arterial blood hemoglobin at 5 minutes after tubation
Time frame: 5 minutes after tubation
Arterial blood lactate at 5 minutes after tubation
Time frame: 5 minutes after tubation
Partial pressure central venous oxygen at 5 minutes after tubation
Time frame: 5 minutes after tubation
Central venous blood oxygen saturation at 5 minutes after tubation
Time frame: 5 minutes after tubation
Oxygen supply index at 5 minutes after tubation
Time frame: 5 minutes after tubation
Oxygen consumption index at 5 minutes after tubation
Time frame: 5 minutes after tubation
Partial pressure of oxygen at 10 minutes after tubation
Time frame: 10 minutes after tubation
Arterial oxygen saturation at 10 minutes after tubation
Time frame: 10 minutes after tubation
Arterial blood hemoglobin at 10 minutes after tubation
Time frame: 10 minutes after tubation
Arterial blood lactate at 10 minutes after tubation
Time frame: 10 minutes after tubation
Partial pressure central venous oxygen at 10 minutes after tubation
Time frame: 10 minutes after tubation
Central venous blood oxygen saturation at 10 minutes after tubation
Time frame: 10 minutes after tubation
Oxygen supply index at 10 minutes after tubation
Time frame: 10 minutes after tubation
Oxygen consumption index at 10 minutes after tubation
Time frame: 10 minutes after tubation
Partial pressure of oxygen at 15 minutes after tubation
Time frame: 15 minutes after tubation
Arterial oxygen saturation at 15 minutes after tubation
Time frame: 15 minutes after tubation
Arterial blood hemoglobin at 15 minutes after tubation
Time frame: 15 minutes after tubation
Arterial blood lactate at 15 minutes after tubation
Time frame: 15 minutes after tubation
Partial pressure central venous oxygen at 15 minutes after tubation
Time frame: 15 minutes after tubation
Central venous blood oxygen saturation at 15 minutes after tubation
Time frame: 15 minutes after tubation
Oxygen supply index at 15 minutes after tubation
Time frame: 15 minutes after tubation
Calculated index at 15 minutes after tubation
Time frame: 15 minutes after tubation
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Apr 2019.
- Background: PubMed 25859171Kako H, Gable A, Martin D, Beebe A, Thung A, Samora W, Klamar J, Bhalla T, Tobias JD. A prospective, open-label trial of clevidipine for controlled hypotension during posterior spinal fusion. J Pediatr Pharmacol Ther. 2015 Jan-Feb;20(1):54-60. doi: 10.5863/1551-6776-20.1.54.
- Background: PubMed 23162401Amr YM, Amin SM. Effects of preoperative beta-blocker on blood loss and blood transfusion during spinal surgeries with sodium nitroprusside-controlled hypotension. Saudi J Anaesth. 2012 Jul;6(3):263-7. doi: 10.4103/1658-354X.101219.
- Individual participant dataSharing planned: No
Related trials for Hypotension,Controlled
Recruiting
Effects of Different MAP Targets on Ocular Perfusion and Optic Nerve Microvasculature During Rhinoplasty
Controlled Hypotension for Nasal Surgeries
Not yet recruiting
Remifentanil vs. Nicardipine for Controlled Hypotension in Elective Nasal Surgery
Nasal Surgery, Anesthesia
Not yet recruiting
Comparison of Two Sedative Agents in Terms of Controlled Hypotension
Controlled Hypotension for Nasal Surgeries
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Yang contact
Cao Yang study director
Guangzhou Red Cross Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Nitroglycerin in people with Hypotension,Controlled, run by Liang Bing at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 16 Apr 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Cao Yang (+86-020-34403854, caoy2008@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
cardiac index(CI) after the participants are taken into the operating room (time frame: during surgery). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03917004, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2019.